跳至主要内容
临床试验/CTRI/2014/10/005131
CTRI/2014/10/005131已完成4 期

Comparison of effectiveness and safety of add on therapy of saroglitazar and fenofibrate with metformin in Indian patients with type 2 diabetes mellitus and predominant hypertriglyceridemia

Dr Pranab Kumar Sahana0 个研究点目标入组 17 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
17

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Newly diagnosed cases of type 2 diabetes mellitus with predominant hypertriglyceridemia
  • 2.Plasma triglyceride level >= 150 mg/dl
  • 3.HbA1C >= 6.5 & <= 8

排除标准

  • 1Female patients who are pregnant or lactating
  • 2.Patients on any oral anti-diabetic drug
  • 3.FPG > 250mg/dl, PPPG > 350mg/dl, LDL-C > 130 mg/dl
  • 4.Co-morbid cardiovascular, renal and psychiatric diseases
  • 5.Co-administration of drugs that are likely to interact with saroglitazar, fenofibrate or metformin and drugs that are likely to alter lipid profile and glycemic status
  • 6.Past history of cardiovascular disease
  • 7.Patients with rising FPG and PPPG levels at week 4 or 8.

研究者

发起方
Dr Pranab Kumar Sahana

相似试验